Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.64 0.00 (-0.02%)
As of: Sep 30, 2026 · 2:05 PM EDT

Biodexa Pharmaceuticals Plc (BDRX) EBIT Margin (2015 - 2018)

Updated

Biodexa Pharmaceuticals (BDRX) recorded EBIT Margin of -2103.41% in the year ended Dec 31, 2023, down 825.59 percentage points from -1277.83% a year earlier.

Analysis

Biodexa Pharmaceuticals Plc (BDRX) EBIT Margin (2015 - 2018) Analysis & Trends

Starting with the year ended Dec 31, 2013, Biodexa Pharmaceuticals' EBIT Margin history includes 11 years.

  • Annual EBIT Margin has a five-year change of -1493.76 percentage points (years ended Dec 2018 to Dec 2023).
  • The figure for the year ended Dec 31, 2023 is the lowest annual EBIT Margin since the year ended Dec 31, 2020.
  • Per Business Quant data, BDRX's EBIT Margin was -1277.83% in the year ended Dec 31, 2022 (-67.10 pp), -1210.73% in the year ended Dec 31, 2021 (+5506.47 pp), -6717.20% in the year ended Dec 31, 2020 (-5037.97 pp) and -1679.23% in the year ended Dec 31, 2019 (-1069.58 pp).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -304.35%
Dec 31, 2017 -120.09%
Dec 31, 2016 -283.11%
Dec 31, 2015 -231.35%
API Access

Biodexa Pharmaceuticals Plc EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=BDRX&period=max&api_key=YOUR_API_KEY